Advancing Immune Precision Through Biologics and Exosome Technology
At Simple Biologics, we are reimagining the future of immune modulation by developing precision biologics and exosome-based therapies that target disease at the cellular level.

Our core mission is to simplify and accelerate the development of next-generation therapeutics that are both effective and safe. We combine synthetic biology, protein engineering, and exosome innovation to create modular platforms capable of precise immune targeting—offering new solutions for cancer, autoimmune disorders, and other chronic diseases.

What Sets Us Apart:

Proprietary platforms for engineering targeted immune responses

Development of biologics with high specificity and reduced toxicity

Integration of exosome delivery systems for enhanced therapeutic precision

Commitment to scalable, real-world applications of advanced biotech

We believe that by removing complexity from biologic design—without sacrificing power—we can transform how medicine is delivered, experienced, and understood.

Our team brings together expertise in immunology, molecular biology, and bioengineering to translate cutting-edge science into accessible therapeutics. At Simple Biologics, innovation is not just about discovery—it's about delivery.

Pipeline Focus Areas:

Engineered biologics for immune reprogramming

Exosome-based delivery and communication systems

Next-gen therapies for oncology, autoimmunity, and rare diseases

We are building a future where biologic therapies are not only powerful, but precisely targeted, minimally invasive, and widely accessible.

Learn more: www.simplebiologics.com

Simple Biologics

Org chart

Teams

Offices

Simple Biologics

Org chart

Teams

Offices

Related companies